Study to Evaluate Multiple Doses in Patients With Nasal Polyposis

Status:
Completed

Trial end date:
2018-01-01

Target enrollment:

Participant gender:

This is a phase 2 study to evaluate multiple doses of AK001 across 2 active doses. Pharmacodynamic activity will also be evaluated.

Phase 2

Allakos, Inc.